Avivagen Inc. reported earnings results for the third quarter and nine months ended July 31, 2023. For the third quarter, the company reported sales was CAD 0.040525 million compared to CAD 0.048606 million a year ago. Net loss was CAD 0.932918 million compared to CAD 1.9 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.03 a year ago.
For the nine months, sales was CAD 0.184247 million compared to CAD 0.408201 million a year ago. Net loss was CAD 3.33 million compared to CAD 4.76 million a year ago. Basic loss per share from continuing operations was CAD 0.04 compared to CAD 0.07 a year ago.